Enoxaparin sodium +/- edoxaban vs edoxaban alone in volunteers

Trial Profile

Enoxaparin sodium +/- edoxaban vs edoxaban alone in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Aug 2012

At a glance

  • Drugs Edoxaban (Primary) ; Enoxaparin sodium
  • Indications Deep vein thrombosis; Embolism; Myocardial infarction; Small cell lung cancer; Stroke; Thromboembolism; Unstable angina pectoris; Venous thromboembolism
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 01 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top